Q & M Dental Group (Singapore) Limited (SG:QC7) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Q & M Dental Group’s subsidiary, Acumen Diagnostics, faces a setback as its clinical laboratory service licence will expire on September 15, 2024, due to unsuccessful attempts to transfer the licence from Dr. Ong Siew Hwa to the company. Acumen has halted related operations and is contemplating applying for a new licence. The impact of this change on the Group’s financial performance for the year is under review, with further updates to be provided to shareholders.
For further insights into SG:QC7 stock, check out TipRanks’ Stock Analysis page.